Attention-deficit/hyperactivity disorder (ADHD) diagnoses have increased among adults in recent years, while remaining stable among teenagers. ADHD diagnoses among adults increased by 15% between 2020 and 2023, after declining by nearly 11% from 2016 to 2020, researchers… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute […]
Published on January 21, 2025
Hormone replacement therapy to ease menopause symptoms doesn’t increase a woman’s risk of brain tumors. Researchers found no link between hormone therapy and gliomas, the most common brain tumors in adults, according to results of a new study published recently in the… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]
Published on January 21, 2025
The U.S. Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray Spravato to treat adults with major depressive disorder (MDD), the company said on Tuesday. The approval paves the way for use of Spravato in patients whose disease has stopped… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]
Published on January 21, 2025